Table 2. Characteristics of individual studies included in the scoping review.
No. | ID | Estimation method | Key populations | Study settings |
|---|---|---|---|---|
1 | E B Hook et al. | Capture-recapture | The key populations | The United States |
2 | M C Buster et al. | Capture-recapture | PWID | Amsterdam |
3 | Ruiz MS et al. | Capture-recapture | PWID | Washington DC |
4 | Apodaca K et al. | Capture-recapture | MSM | Uganda |
5 | Karami M et al. | Capture-recapture | CSW | Tehran, Iran |
6 | Doshi RH et al. | Capture-recapture | PWID, MSM, and CSW | Kampala, Uganda |
7 | Li G et al. | Capture-recapture | MSM | Beijing, China |
8 | Sulaberidze L et al. | Multiplier | MSM | Tbilisi, Georgia |
9 | Okal J et al. | Multiplier | PWID, MSM, and CSW | Nairobi, Kenya |
10 | Paz-Bailey G et al. | Multiplier | MSM and CSW | El Salvador |
11 | Burrell ER et al. | Multiplier | MSM | the United States |
12 | Rich AJ et al. | Multiplier | MSM | Metro Vancouver, Canada |
13 | Hiebert L et al. | Multiplier | PWID | Malaysia |
14 | Khalid FJ et al. | Delphi | PWID, MSM, and CSW | Unguja Island, Zanzibar |
15 | Okal J et al. | Delphi | PWID, MSM and CSW | Nairobi, Kenya |
16 | Bunjaku DG et al. | Mapping | PWID, MSM and CSW | Kosovo |
17 | Odek WO et al. | Mapping | CSW | Kenya |
18 | Wambura M et al. | Mapping | MSM and CSW | Tanzania |
19 | Lu F, Wang N et al. | Workbook | The key populations | China |
20 | Ha NTT et al. | Workbook | PWID | Son La, Vietnam |
21 | Lansky A et al. | Workbook | heterosexual persons | the United States |
22 | Scholz SM et al. | Network scale-up | MSM | Germany |
23 | Baral S et al. | Network scale-up | MSM | Multiple countries |
24 | Guo J et al. | Network scale-up | MSM | Beijing, China |
25 | Ezoe S et al. | Network scale-up | MSM | Japan |
26 | Maghsoudi A et al. | Network scale-up | PWID and CSW | Iran |
27 | Wang J et al. | Network scale-up | MSM | Shanghai, China |
28 | Bengtsson L et al. | Respondent-driven sampling | MSM | Vietnam |
29 | Holland CE et al. | Respondent-driven sampling | MSM and CSW | Burkina Faso and Togo |
30 | Johnston LG et al. | Respondent-driven sampling | males who inject drugs | Myanmar |
31 | Carballo-Diéguez A et al. | Respondent-driven sampling | MSM | Buenos Aires |
32 | Buchanan R et al. | Respondent-driven sampling | PWID | Multiple countries |
33 | Lachowsky NJ et al. | Respondent-driven sampling | MSM | Vancouver, Canada |
34 | Overall AM et al. | Bayesian estimation | PWID | Scotland |
35 | Datta A et al. | Bayesian estimation | MSM | Côte d'Ivoire |
36 | Bao L et al. | Bayesian estimation | PWID | Bangladesh |
37 | Nakagawa F et al. | Stochastic simulation | HIV-positive MSM | UK |
38 | Chen H (2013) et al. | Laska-Meisner-Siegel estimation | MSM | Changsha, China |
39 | Chen H (2011) et al. | Laska-Meisner-Siegel estimation | MSM | One city in China |